• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 100 of 100
BRITAIN-PHARMACEUTICAL-GSK
GSK cuts U.S. research and sales jobs as market gets tougher
By ReutersDecember 4, 2014
Images Of Over-The-Counter Medicines And Dietary Supplements By Japanese Drugmakers
Features
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By Laura LorenzettiDecember 2, 2014
Las Vegas Hit By Economic Downturn
Finance
Wynn Resorts under investigation for potential money laundering
By Tom Huddleston Jr.November 21, 2014
Valeant Offers to Buy Allergan With Pershing's Support
After losing out over Allergan, Valeant announces $2 billion buyback
By Geoffrey SmithNovember 21, 2014
Your pharmacist called. You owe $1.3 trillion.
Features
Your pharmacist called. You owe $1.3 trillion.
By Erika FryNovember 20, 2014
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
Pfizer to pay up to $2 billion for cancer alliance with Germany’s Merck
By Geoffrey SmithNovember 17, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
Finance
Allergan in talks with another bidder as it looks to thwart Valeant
By Laura LorenzettiNovember 6, 2014
CVS Caremark Reports Quarterly Profit Increase Of 25 Percent
Retail
CVS Health’s tobacco ban hits retail sales after one month
By Laura LorenzettiNovember 4, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
Leadership
Sanofi’s CEO ouster: A snowball of bad judgment calls
By Eleanor BloxhamOctober 30, 2014
Chris Viehbacher, Chief Executive Officer Of Sanofi Interview
Leadership
Sanofi fires CEO after profit warning on key drug
By Geoffrey SmithOctober 29, 2014
Google X goes teeny-tiny to diagnose disease at its earliest stages
Features
Google X goes teeny-tiny to diagnose disease at its earliest stages
By Laura LorenzettiOctober 28, 2014
Pfizer’s sales beats expectations even as top drugs lose patent protections
Finance
Pfizer’s sales beats expectations even as top drugs lose patent protections
By Laura LorenzettiOctober 28, 2014
NIGERIA-HEALTH-DISEASE-EPIDEMIC-EBOLA-LIBERIA
Technical hurdles, not funding, could hinder race for Ebola vaccines
By ReutersOctober 27, 2014
Laid-Off Workers Get Employment Tips And Free Botox Treatments
Finance
Allergan firms up its profit as it continues to rebuff Valeant’s advances
By Laura LorenzettiOctober 27, 2014
Technology
Finance
Merck’s cost cutting pays off as results beat expectations
By Laura LorenzettiOctober 27, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.